PUBPAT

Supreme Court orders reconsideration of breast cancer gene patent decision

Yesterday, the Supreme Court vacated Association for Molecular Pathology v. Myriad Genetics and remanded the case for further consideration in light of last week's Prometheus decision, which stated that the laws of nature are unpatentable. The Myriad case concerns the patentability of the BRCA1 and BRCA2 breast cancer genes. » Read more

3 Comments